The efficacy of the dual sEH/FXR modulator 7 was demonstrated in two models of NASH–the streptozotocin-induced mice and the choline-deficient high-fat diet induced mice (Takahashi et al., 2012). Here, EPHX2 is linked to metabolic dysfunction-associated steatohepatitis.